Literature DB >> 26990584

Outbreak of respiratory syncytial virus (RSV) infection in immunocompromised adults on a hematology ward.

Tomas Ostergaard Jensen1,2, Sacha Stelzer-Braid2,3, Christiana Willenborg3, Carol Cheung4, David Andresen1, William Rawlinson2,3,5, Kate Clezy6.   

Abstract

We describe an outbreak of respiratory syncytial virus (RSV) infection on a hematology ward without allogeneic stem cell transplant patients. Twelve patients and one staff member infected with RSV were identified from the laboratory database. Five patients had lower respiratory tract infection, seven had upper respiratory tract infection, one was asymptomatic, and there were two (15.4%) deaths. Most patients had overlapping periods of potential infectiousness on the ward. Sequencing was possible on eight specimens and five of these had identical sequences. Results were consistent with transmission occurring both on the ward and by introduction of RSV from the community. J. Med. Virol. 88:1827-1831, 2016.
© 2016 Wiley Periodicals, Inc. © 2016 Wiley Periodicals, Inc.

Entities:  

Keywords:  adults; epidemiology; hematology; immunosuppression; respiratory syncytial virus

Mesh:

Year:  2016        PMID: 26990584     DOI: 10.1002/jmv.24521

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  9 in total

1.  Target capture sequencing reveals a monoclonal outbreak of respiratory syncytial virus B infections among adult hematologic patients.

Authors:  Claas Baier; Jiabin Huang; Kerstin Reumann; Daniela Indenbirken; Felicitas Thol; Christian Koenecke; Ella Ebadi; Albert Heim; Franz-Christoph Bange; Sibylle Haid; Thomas Pietschmann; Nicole Fischer
Journal:  Antimicrob Resist Infect Control       Date:  2022-06-21       Impact factor: 6.454

2.  Risk factor-based analysis of community-acquired pneumonia, healthcare-associated pneumonia and hospital-acquired pneumonia: Microbiological distribution, antibiotic resistance, and clinical outcomes.

Authors:  Hakjun Hyun; Joon Young Song; Jin Gu Yoon; Hye Seong; Ji Yun Noh; Hee Jin Cheong; Woo Joo Kim
Journal:  PLoS One       Date:  2022-06-29       Impact factor: 3.752

3.  Infection prevention requirements for the medical care of immunosuppressed patients: recommendations of the Commission for Hospital Hygiene and Infection Prevention (KRINKO) at the Robert Koch Institute.

Authors: 
Journal:  GMS Hyg Infect Control       Date:  2022-04-13

4.  Exchange Proteins Directly Activated by cAMP and Their Roles in Respiratory Syncytial Virus Infection.

Authors:  Eun-Jin Choi; Yuping Ren; Yu Chen; Shengxuan Liu; Wenzhe Wu; Junping Ren; Pingyuan Wang; Roberto P Garofalo; Jia Zhou; Xiaoyong Bao
Journal:  J Virol       Date:  2018-10-29       Impact factor: 5.103

5.  Substituted N-(4-amino-2-chlorophenyl)-5-chloro-2-hydroxybenzamide analogues potently inhibit respiratory syncytial virus (RSV) replication and RSV infection-associated inflammatory responses.

Authors:  Jimin Xu; Wenzhe Wu; Haiying Chen; Yu Xue; Xiaoyong Bao; Jia Zhou
Journal:  Bioorg Med Chem       Date:  2021-04-18       Impact factor: 3.461

6.  Molecular characteristics and successful management of a respiratory syncytial virus outbreak among pediatric patients with hemato-oncological disease.

Authors:  Claas Baier; Sibylle Haid; Thomas Pietschmann; Franz-Christoph Bange; Andreas Beilken; Astrid Behnert; Martin Wetzke; Richard J P Brown; Corinna Schmitt; Ella Ebadi; Gesine Hansen; Thomas F Schulz
Journal:  Antimicrob Resist Infect Control       Date:  2018-02-13       Impact factor: 4.887

7.  Consecutive yearly outbreaks of respiratory syncytial virus in a haemato-oncology ward and efficacy of infection control measures.

Authors:  T Inkster; K Ferguson; A Edwardson; R Gunson; R Soutar
Journal:  J Hosp Infect       Date:  2017-05-06       Impact factor: 3.926

Review 8.  Transmission and Control of Respiratory Viral Infections in the Healthcare Setting.

Authors:  Pablo E Bonvehí; Elena R Temporiti
Journal:  Curr Treat Options Infect Dis       Date:  2018-04-30

9. 

Authors: 
Journal:  Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz       Date:  2021-02       Impact factor: 1.513

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.